Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol

NCT01451645 is registered in ClinicalTrials.gov with Regeneron Pharmaceuticals as lead sponsor.

NCT NCT01451645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01451645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol
Lead sponsor
Regeneron Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2011
Completion date
September 30, 2012
Enrollment
82 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

intercritical gout